The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer

OBJECTIVE: Kirsten rat sarcoma viral oncogene homolog (KRAS) is an important driver gene of non‐small cell lung cancer (NSCLC). Despite a rapid progress achieved in the targeted therapy, chemotherapy remains the standard treatment option for patients with KRAS‐mutant NSCLC. This study aimed to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hanxiao, Huang, Dingzhi, Lin, Gen, Yang, Xue, Zhuo, Minglei, Chi, Yujia, Zhai, Xiaoyu, Jia, Bo, Wang, Jingjing, Wang, Yuyan, Li, Jianjie, An, Tongtong, Wu, Meina, Wang, Ziping, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554448/
https://www.ncbi.nlm.nih.gov/pubmed/35394121
http://dx.doi.org/10.1002/cam4.4739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554448/
https://www.ncbi.nlm.nih.gov/pubmed/35394121
http://dx.doi.org/10.1002/cam4.4739

Ejemplares similares